The Molecular App Company™
QIAGEN and GT Molecular collaborate to offer SARS-CoV-2 VARIANT PANEL
wastewater detection based on QIAcuity Digital PCR technology
wastewater detection based on QIAcuity Digital PCR technology
Who we are
Applications
- SARS-CoV-2 | COVID-19 | Variants
- Pathogen detection
- Genetically Modified Organisms (GMO)
- Rare sequence detection in cancer and disease
- Gene expression analysis
- Next-Generation Sequencing (NGS)
Clients
- Hostpitals and Pathology Laboratories
- Research Laboratories and Academic Instituations
- Clinical Research Organizations
- Pharmaceutical and Biotechnology
- Forensic Laboratories
- Municipalities and wastewater treatment facilities